Managing the Refractory Idiopathic Overactive Bladder with OnabotulinumtoxinA: Phase 2 Trial

被引：0
|
作者：
Boone T.B. [1 ]
机构：
[1] Department of Urology, The Methodist Hospital, Methodist Neurological Institute, Houston, TX, 77030, 6560 Fannin
来源：
Current Bladder Dysfunction Reports | 2011年 / 6卷 / 2期
关键词：
Botulinum Toxin; Detrusor Overactivity; Anticholinergic Medication; onabotulinumtoxinA; Urinary Urgency Incontinence;
D O I：
10.1007/s11884-011-0082-y
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：65 / 66
页数：1
相关论文
共 50 条
  • [21] Sacral neuromodulation for refractory overactive bladder after prior intravesical onabotulinumtoxinA treatment
    Hoag, N.
    Plagakis, S.
    Pillay, S.
    Edwards, A. Wilson
    Gani, J.
    BJU INTERNATIONAL, 2016, 117 : 68 - 68
  • [22] Intravesical Instillation of OnabotulinumtoxinA in the Treatment of Refractory Overactive Bladder in Participants with Urinary Incontinence
    Chermansky, Christopher J.
    Richter, Holly E.
    Jacoby, Karny
    Titanji, Wilson
    Jenkins, Brenda
    Geib, Till
    Brucker, Benjamin M.
    JOURNAL OF UROLOGY, 2022, 208 (04): : 855 - 862
  • [23] Sacral neuromodulation for refractory overactive bladder after prior intravesical onabotulinumtoxinA treatment
    Hoag, Nathan
    Plagakis, Sophie
    Pillay, Samantha
    Edwards, Ailsa Wilson
    Gani, Johan
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 (05) : 1377 - 1381
  • [24] OnabotulinumtoxinA for Overactive Bladder and Urinary Incontinence
    Chancellor, Michael B.
    JOURNAL OF UROLOGY, 2017, 197 (02): : S224 - S236
  • [25] Efficacy and Safety of OnabotulinumtoxinA for Idiopathic Overactive Bladder: A Double-Blind, Placebo Controlled, Randomized, Dose Ranging Trial
    Dmochowski, Roger
    Chapple, Christopher
    Nitti, Victor W.
    Chancellor, Michael
    Everaert, Karel
    Thompson, Catherine
    Daniell, Grace
    Zhou, Jihao
    Haag-Molkenteller, Cornelia
    JOURNAL OF UROLOGY, 2010, 184 (06): : 2416 - 2422
  • [26] 50 Unit Dose of OnabotulinumtoxinA for Initial Treatment of Idiopathic Overactive Bladder in Older Women
    Tam, J.
    Lee, W.
    Lacombe, J.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2022, 33 (SUPPL 2) : S484 - S485
  • [27] Real-World Retention Rates After Intravesical OnabotulinumtoxinA for Idiopathic Overactive Bladder
    Liberman, Daniel
    Milhouse, Olufenwa
    Johnson-Mitchell, Marta
    Siegel, Steven W.
    FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2018, 24 (06): : 404 - 407
  • [28] SACRAL NEUROMODULATION FOR REFRACTORY OVERACTIVE BLADDER AFTER PRIOR INTRAVESICAL ONABOTULINUMTOXINA TREATMENT.
    Hoag, Nathan
    Plagakis, Sophie
    Pillay, Samantha
    Edwards, Ailsa Wilson
    Gani, Johan
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1021 - E1021
  • [29] Re: The Use of OnabotulinumtoxinA to Treat Idiopathic Overactive Bladder in Elderly Patients Is in Need of Study
    Wein, Alan J.
    JOURNAL OF UROLOGY, 2022, 208 (01): : 220 - 221
  • [30] Intravesical Injection of OnabotulinumtoxinA (Botulinum Toxin Type A) in Japanese Patients With Refractory Overactive Bladder
    Gotoh, Daisuke
    Torimoto, Kazumasa
    Takamatsu, Norimi
    Onishi, Kenta
    Morizawa, Yosuke
    Hori, Shunta
    Nakai, Yasushi
    Miyake, Makito
    Fujimoto, Kiyohide
    IN VIVO, 2024, 38 (03): : 1332 - 1337
12345